UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world

Therapeutic advances in neurological disorders, 2017-10, Vol.10 (10), p.343-359

2017

Volltextzugriff (PDF)

Molecular biomarkers in multiple sclerosis

Journal of neuroinflammation, 2019-12, Vol.16 (1), p.272-272, Article 272

2019

Volltextzugriff (PDF)

The Investigation of the Cardiovascular and Sudomotor Autonomic Nervous System-A Review

Frontiers in neurology, 2019-02, Vol.10, p.53-53

2019

Volltextzugriff (PDF)

The role of TH17 cells in multiple sclerosis: Therapeutic implications

Autoimmunity reviews, 2020-10, Vol.19 (10), p.102647, Article 102647

2020

Volltextzugriff (PDF)

A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition

Journal of neurology, 2021-04, Vol.268 (4), p.1210-1221

2021

Volltextzugriff (PDF)

Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis

Scientific reports, 2020-04, Vol.10 (1), p.5941-5941, Article 5941

2020

Volltextzugriff (PDF)

Spectral Analysis of Heart Rate Variability: Time Window Matters

Frontiers in neurology, 2019-05, Vol.10, p.545-545

2019

Volltextzugriff (PDF)

Demands on response inhibition processes determine modulations of theta band activity in superior frontal areas and correlations with pupillometry – Implications for the norepinephrine system during inhibitory control

NeuroImage (Orlando, Fla.), 2017-08, Vol.157, p.575-585

2017

Volltextzugriff (PDF)

Digital Twins for Multiple Sclerosis

Frontiers in immunology, 2021-05, Vol.12, p.669811-669811

2021

Volltextzugriff (PDF)

How to reduce the delay of diagnosing secondary progression in multiple sclerosis

Multiple sclerosis, 2021-04, Vol.27 (4), p.646-647

2021

Volltextzugriff (PDF)

Natalizumab during pregnancy and lactation

Multiple sclerosis, 2018-10, Vol.24 (12), p.1627-1634

2018

Volltextzugriff (PDF)

Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors

Multiple sclerosis, 2013-11, Vol.19 (13), p.1792-1799

2013

Volltextzugriff (PDF)

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

Lancet neurology, 2017-03, Vol.16 (3), p.189-199

2017

Volltextzugriff (PDF)

Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease

Movement disorders, 2012-04, Vol.27 (5), p.617-626

2012

Volltextzugriff (PDF)

The need for a strategic therapeutic approach: multiple sclerosis in check

Therapeutic Advances in Chronic Disease, 2022-01, Vol.13, p.20406223211063032-20406223211063032

2022

Volltextzugriff (PDF)

Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC)

Therapeutic advances in neurological disorders, 2022-01, Vol.15, p.17562864221135305-17562864221135305

2022

Volltextzugriff (PDF)

Psychoneuroimmunology - psyche and autoimmunity

Current pharmaceutical design, 2012-10, Vol.18 (29), p.4485-4488

Ziemssen, Tjalf

2012

Volltextzugriff (PDF)

Differentiating societal costs of disability worsening in multiple sclerosis

Journal of neurology, 2020-04, Vol.267 (4), p.1035-1042

2020

Volltextzugriff (PDF)

S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review

Therapeutic Advances in Neurological Disorders, 2022-01, Vol.15, p.17562864221133163-17562864221133163

2022

Volltextzugriff (PDF)

Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2316422-2316422

2024

Volltextzugriff (PDF)

Therapy satisfaction and adherence in patients with relapsing–remitting multiple sclerosis: the THEPA-MS survey

Therapeutic advances in neurological disorders, 2016-07, Vol.9 (4), p.250-263

2016

Volltextzugriff (PDF)

Building digital patient pathways for the management and treatment of multiple sclerosis

Frontiers in immunology, 2024, Vol.15, p.1356436-1356436

2024

Volltextzugriff (PDF)

Acute Effects of Ocrelizumab Infusion in Multiple Sclerosis Patients

International journal of molecular sciences, 2022-11, Vol.23 (22), p.13759

2022

Volltextzugriff (PDF)

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis

Frontiers in immunology, 2021-06, Vol.12, p.701752-701752

2021

Volltextzugriff (PDF)

A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity

Nature immunology, 2017-06, Vol.18 (6), p.654-664

2017

Volltextzugriff (PDF)

1 – 25 von 635

Suche als RSS-Feed

Aktive Filter

Publikationsformmagazinearticle

PublikationsformBerichte

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(556)
Mit Volltextzugriff
(458)

Publikationsform

Artikel
(619)
Buchkapitel
(14)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(395)
Life Sciences & Biomedicine
(381)
Multiple Sclerosis
(247)
Neurosciences & Neurology
(236)
Humans
(210)
Clinical Neurology
(188)
Neurosciences
(148)
Male
(121)
Female
(117)
Neurology
(106)
Adult
(91)
Patients
(84)
Middle Aged
(83)
Medicine
(56)
Medicine & Public Health
(51)
Young Adult
(42)
Aged
(39)
Immunology
(39)
Magnetic Resonance Imaging
(37)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neurology
(111)
Frontiers In Neurology
(26)
Multiple Sclerosis
(20)
Multiple Sclerosis And Related Disorders
(20)
Therapeutic Advances In Neurological Disorders
(19)
Der Neurologe & Psychiater : Dnp
(17)
Journal Of Neurology
(15)
Frontiers In Immunology
(12)
Bmc Neurology
(10)
Brain Sciences
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world

Molecular biomarkers in multiple sclerosis

The Investigation of the Cardiovascular and Sudomotor Autonomic Nervous System-A Review

The role of TH17 cells in multiple sclerosis: Therapeutic implications

A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition

Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis

Spectral Analysis of Heart Rate Variability: Time Window Matters

Demands on response inhibition processes determine modulations of theta band activity in superior frontal areas and correlations with pupillometry – Implications for the norepinephrine system during inhibitory control

Digital Twins for Multiple Sclerosis

How to reduce the delay of diagnosing secondary progression in multiple sclerosis

Natalizumab during pregnancy and lactation

Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease

The need for a strategic therapeutic approach: multiple sclerosis in check

Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC)

Psychoneuroimmunology - psyche and autoimmunity

Differentiating societal costs of disability worsening in multiple sclerosis

S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review

Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab

Therapy satisfaction and adherence in patients with relapsing–remitting multiple sclerosis: the THEPA-MS survey

Building digital patient pathways for the management and treatment of multiple sclerosis

Acute Effects of Ocrelizumab Infusion in Multiple Sclerosis Patients

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis

A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity

Aktive Filter

Suchergebnisse filtern